Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Shi Quan

Showing results (1-10 of 230) with videos related to

Pageof 23
Sort By:
Nanomedicine (London, England)|June 18, 2025
Applications of virus-like particles in the prevention of protozoan parasite infectionKi Back Chu, Fu-Shi Quan
Vaccines|April 30, 2021
Advances in <i>Toxoplasma gondii</i> Vaccines: Current Strategies and Challenges for Vaccine DevelopmentKi-Back Chu, Fu-Shi Quan
Vaccines|August 28, 2025
Efficacy of Heterologous Vaccination Using Virus-Like Particles and Vaccinia Virus Containing MIC8 and AMA1 Proteins of <i>Toxoplasma gondii</i>Hae-Ji Kang, Fu-Shi Quan
Current Topics in Microbiology and Immunology|March 2, 2021
Virus-Like Particle Vaccines Against Respiratory Viruses and Protozoan ParasitesKi-Back Chu, Fu-Shi Quan
Viruses|February 28, 2023
Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?Ki-Back Chu, Fu-Shi Quan
Parasites, Hosts and Diseases|August 30, 2023
Recent progress in vaccine development targeting pre-clinical human toxoplasmosisKi-Back Chu, Fu-Shi Quan
Malaria Journal|May 1, 2019
Plasmodium knowlesi clinical isolates from Malaysia show extensive diversity and strong differential selection pressure at the merozoite surface protein 7D (MSP7D)Md Atique Ahmed, Fu-Shi Quan
Vaccine|June 19, 2016
Protection induced by early stage vaccination with pandemic influenza virus-like particlesGi-Ja Lee, Fu-Shi Quan
Acta Biochimica Et Biophysica Sinica|August 21, 2016
Medical applications of the intrinsic mechanical properties of single cellsFu-Shi Quan, Kyung Sook Kim
Acta Tropica|August 31, 2025
Recombinant vaccinia virus expressing MIC8, AMA1, or RON4 induce protection against Toxoplasma gondii ME49 strain infectionHae-Ji Kang, Fu-Shi Quan
Pageof 23

Showing results (1-10 of 230) with videos related to

Sort By:
Pageof 23
Nanomedicine (London, England)|June 18, 2025
Applications of virus-like particles in the prevention of protozoan parasite infectionKi Back Chu, Fu-Shi Quan
Vaccines|April 30, 2021
Advances in <i>Toxoplasma gondii</i> Vaccines: Current Strategies and Challenges for Vaccine DevelopmentKi-Back Chu, Fu-Shi Quan
Vaccines|August 28, 2025
Efficacy of Heterologous Vaccination Using Virus-Like Particles and Vaccinia Virus Containing MIC8 and AMA1 Proteins of <i>Toxoplasma gondii</i>Hae-Ji Kang, Fu-Shi Quan
Current Topics in Microbiology and Immunology|March 2, 2021
Virus-Like Particle Vaccines Against Respiratory Viruses and Protozoan ParasitesKi-Back Chu, Fu-Shi Quan
Viruses|February 28, 2023
Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?Ki-Back Chu, Fu-Shi Quan
Parasites, Hosts and Diseases|August 30, 2023
Recent progress in vaccine development targeting pre-clinical human toxoplasmosisKi-Back Chu, Fu-Shi Quan
Malaria Journal|May 1, 2019
Plasmodium knowlesi clinical isolates from Malaysia show extensive diversity and strong differential selection pressure at the merozoite surface protein 7D (MSP7D)Md Atique Ahmed, Fu-Shi Quan
Vaccine|June 19, 2016
Protection induced by early stage vaccination with pandemic influenza virus-like particlesGi-Ja Lee, Fu-Shi Quan
Acta Biochimica Et Biophysica Sinica|August 21, 2016
Medical applications of the intrinsic mechanical properties of single cellsFu-Shi Quan, Kyung Sook Kim
Acta Tropica|August 31, 2025
Recombinant vaccinia virus expressing MIC8, AMA1, or RON4 induce protection against Toxoplasma gondii ME49 strain infectionHae-Ji Kang, Fu-Shi Quan
Pageof 23